Recognition List Number: 029 Publication Date: 08/20/2012
Part B: SUPPLEMENTARY INFORMATION
Recognition Number 3-56: ASTM F1841-97 (2005), Standard Practice for Assessment of Hemolysis in Continuous Flow Blood Pumps. (Cardiovascular)
Date of Standard: 2005. |
| Address of Standards Organization: |
| ASTM International (ASTM) |
| 100 Barr Harbor Drive |
| West Conshohocken, PA 19428-2959 |
| |
|
| CDRH Office and Division Associated with Recognized Standards: |
| OFFICE OF DEVICE EVALUATION (ODE) | | DIVISION OF CARDIOVASCULAR DEVICES (DCD) |
|
|
| Devices Affected: |
| Continuous Flow Blood Pumps for Short Term (<=6 HRS) Durations of Use |
|
| Processes Affected: |
| 510(k), PMA, IDE, PDP, HDE, Design Control Input, Quality System Regulation |
|
| Type of Standard: |
| International, Vertical |
| Extent of Recognition: |
Complete Standard except as noted below
NOTE: In general, this standard provides some basic guidelines for performing hemolysis testing on blood pumps expected to be use for up to 6 hours. Short-term bench-top hemolysis testing is not sufficient for making regulatory decisions for devices intended for long-term use (greater than 6 hours duration), and should only be considered useful for supplementary testing at conditions beyond those which might be performed in animals. Due to variations in the design and clinical use of different blood pumps, the test methodology and parameters (e.g. flow rate, pressure, temperature) described in the ASTM F1841 standard may need to be adjusted. |
|
| Related CFR Citations and Product Codes: |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §870.4360 |
Pump, Blood, Cardiopulmonary Bypass, Non-Roller Type |
Class 3 |
KFM |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §870.4370 |
Pump, Blood, Cardiopulmonary Bypass, Roller Type |
Class 2 |
DWB |
| |
|
| Relevant Guidance: |
| There is no relevant guidance developed at this time. |
|
| FDA Technical Contacts: |
|
|
| Jean E. Rinaldi |
| FDA/CDRH/OSEL |
| 10903 New Hampshire Avenue Building 62, Room 2220 |
| Silver Spring MD 20993 |
| 301/796-2523 |
| Email: jean.rinaldi@fda.hhs.gov |
|
|